share_log

We Think Hongmian Zhihui Science and Technology InnovationLtd.Guangzhou's (SZSE:000523) Solid Earnings Are Understated

We Think Hongmian Zhihui Science and Technology InnovationLtd.Guangzhou's (SZSE:000523) Solid Earnings Are Understated

我們認爲紅棉智匯科技創新有限公司廣州(SZSE: 000523)的穩健收益被低估了
Simply Wall St ·  05/01 18:05

Hongmian Zhihui Science and Technology Innovation Co.,Ltd.Guangzhou's (SZSE:000523) recent earnings report didn't offer any surprises, with the shares unchanged over the last week. We did some analysis to find out why and believe that investors might be missing some encouraging factors contained in the earnings.

紅棉智匯科技創新有限公司, Ltd.Guangzhou(深圳證券交易所股票代碼:000523)最近的業績並未帶來任何意外,該股上週保持不變。我們進行了一些分析以找出原因,並認爲投資者可能遺漏了收益中包含的一些令人鼓舞的因素。

earnings-and-revenue-history
SZSE:000523 Earnings and Revenue History May 1st 2024
SZSE: 000523 2024 年 5 月 1 日的收益和收入歷史記錄

A Closer Look At Hongmian Zhihui Science and Technology InnovationLtd.Guangzhou's Earnings

仔細看看廣州紅棉智匯科技創新有限公司的收益

Many investors haven't heard of the accrual ratio from cashflow, but it is actually a useful measure of how well a company's profit is backed up by free cash flow (FCF) during a given period. In plain english, this ratio subtracts FCF from net profit, and divides that number by the company's average operating assets over that period. You could think of the accrual ratio from cashflow as the 'non-FCF profit ratio'.

許多投資者還沒有聽說過現金流的應計比率,但它實際上是衡量公司在給定時期內自由現金流(FCF)在多大程度上支持利潤的有用指標。簡而言之,該比率從淨利潤中減去FCF,然後將該數字除以該時期公司的平均運營資產。你可以將現金流的應計比率視爲 “非FCF利潤率”。

That means a negative accrual ratio is a good thing, because it shows that the company is bringing in more free cash flow than its profit would suggest. While it's not a problem to have a positive accrual ratio, indicating a certain level of non-cash profits, a high accrual ratio is arguably a bad thing, because it indicates paper profits are not matched by cash flow. Notably, there is some academic evidence that suggests that a high accrual ratio is a bad sign for near-term profits, generally speaking.

這意味着負應計比率是一件好事,因爲它表明該公司帶來的自由現金流超出了其利潤所暗示的範圍。儘管應計比率爲正(表明非現金利潤達到一定水平)不是問題,但高應計比率可以說是一件壞事,因爲它表明紙質利潤與現金流不匹配。值得注意的是,有一些學術證據表明,總的來說,高應計比率對短期利潤來說是個壞兆頭。

Hongmian Zhihui Science and Technology InnovationLtd.Guangzhou has an accrual ratio of -0.20 for the year to March 2024. Therefore, its statutory earnings were very significantly less than its free cashflow. To wit, it produced free cash flow of CN¥268m during the period, dwarfing its reported profit of CN¥87.0m. Given that Hongmian Zhihui Science and Technology InnovationLtd.Guangzhou had negative free cash flow in the prior corresponding period, the trailing twelve month resul of CN¥268m would seem to be a step in the right direction. Having said that it seems that a recent tax benefit and some unusual items have impacted its profit (and this its accrual ratio).

截至2024年3月的一年中,廣州紅棉智匯科技創新有限公司的應計比率爲-0.20。因此,其法定收入大大低於其自由現金流。換句話說,它在此期間產生的自由現金流爲2.68億元人民幣,與其報告的8,700萬元人民幣利潤相形見絀。鑑於廣州紅棉智匯科技創新有限公司在前一同期的自由現金流爲負,過去十二個月的2.68億元人民幣的業績似乎是朝着正確方向邁出的一步。話雖如此,最近的稅收優惠和一些不尋常的項目似乎影響了其利潤(以及應計比率)。

Note: we always recommend investors check balance sheet strength. Click here to be taken to our balance sheet analysis of Hongmian Zhihui Science and Technology InnovationLtd.Guangzhou.

注意:我們始終建議投資者檢查資產負債表的實力。點擊此處查看我們對廣州紅棉智匯科技創新有限公司的資產負債表分析。

The Impact Of Unusual Items On Profit

不尋常物品對利潤的影響

Hongmian Zhihui Science and Technology InnovationLtd.Guangzhou's profit was reduced by unusual items worth CN¥37m in the last twelve months, and this helped it produce high cash conversion, as reflected by its unusual items. This is what you'd expect to see where a company has a non-cash charge reducing paper profits. While deductions due to unusual items are disappointing in the first instance, there is a silver lining. We looked at thousands of listed companies and found that unusual items are very often one-off in nature. And, after all, that's exactly what the accounting terminology implies. Assuming those unusual expenses don't come up again, we'd therefore expect Hongmian Zhihui Science and Technology InnovationLtd.Guangzhou to produce a higher profit next year, all else being equal.

在過去的十二個月中,廣州紅棉智匯科技創新有限公司的利潤因價值3700萬元人民幣的不尋常物品而減少,這幫助其產生了很高的現金轉化率,其不尋常的項目就反映了這一點。這就是你所期望看到的公司的非現金費用會減少紙面利潤的情況。儘管由於不尋常項目而產生的扣除首先令人失望,但有一線希望。我們調查了數千家上市公司,發現不尋常的物品本質上往往是一次性的。而且,畢竟,這正是會計術語的含義。假設這些不尋常的支出不會再次出現,因此,我們預計廣州紅棉智匯科技創新有限公司在其他條件相同的情況下,明年將產生更高的利潤。

An Unusual Tax Situation

不尋常的稅收狀況

Moving on from the accrual ratio, we note that Hongmian Zhihui Science and Technology InnovationLtd.Guangzhou profited from a tax benefit which contributed CN¥34m to profit. This is of course a bit out of the ordinary, given it is more common for companies to be paying tax than receiving tax benefits! We're sure the company was pleased with its tax benefit. And given that it lost money last year, it seems possible that the benefit is evidence that it now expects to find value in its past tax losses. However, the devil in the detail is that these kind of benefits only impact in the year they are booked, and are often one-off in nature. In the likely event the tax benefit is not repeated, we'd expect to see its statutory profit levels drop, at least in the absence of strong growth.

從應計比率來看,我們注意到廣州紅棉智匯科技創新有限公司從一項稅收優惠中獲利,該優惠爲利潤貢獻了3400萬元人民幣。這當然有點不尋常,因爲公司納稅比獲得稅收優惠更爲普遍!我們確信該公司對其稅收優惠感到滿意。而且,鑑於它去年虧損,這種好處似乎有可能證明它現在有望從過去的稅收損失中找到價值。但是,細節上的問題在於,此類福利僅在預訂當年有影響,而且本質上通常是一次性的。如果稅收優惠可能不重演,我們預計其法定利潤水平將下降,至少在沒有強勁增長的情況下是如此。

Our Take On Hongmian Zhihui Science and Technology InnovationLtd.Guangzhou's Profit Performance

我們對廣州紅棉智匯科技創新有限公司盈利表現的看法

In conclusion, both Hongmian Zhihui Science and Technology InnovationLtd.Guangzhou's accrual ratio and its unusual items suggest that its statutory earnings are probably reasonably conservative, but the presence of a tax benefits may be inflating the numbers in a way that won't persist. Based on these factors, we think Hongmian Zhihui Science and Technology InnovationLtd.Guangzhou's earnings potential is at least as good as it seems, and maybe even better! Keep in mind, when it comes to analysing a stock it's worth noting the risks involved. For example - Hongmian Zhihui Science and Technology InnovationLtd.Guangzhou has 1 warning sign we think you should be aware of.

總之,廣州紅棉智匯科技創新有限公司的應計比率及其不尋常的項目都表明,其法定收益可能相當保守,但稅收優惠的存在可能會以一種不會持續的方式誇大這一數字。基於這些因素,我們認爲廣州紅棉智匯科技創新有限公司的盈利潛力至少和看上去一樣好,甚至可能更好!請記住,在分析股票時,值得注意所涉及的風險。例如,廣州紅棉智匯科技創新有限公司有 1 個我們認爲你應該注意的警告標誌。

Our examination of Hongmian Zhihui Science and Technology InnovationLtd.Guangzhou has focussed on certain factors that can make its earnings look better than they are. And it has passed with flying colours. But there is always more to discover if you are capable of focussing your mind on minutiae. For example, many people consider a high return on equity as an indication of favorable business economics, while others like to 'follow the money' and search out stocks that insiders are buying. While it might take a little research on your behalf, you may find this free collection of companies boasting high return on equity, or this list of stocks that insiders are buying to be useful.

我們對廣州紅棉智匯科技創新有限公司的審查側重於某些可能使其收益看起來好於實際的因素。而且它已經以優異的成績過去了。但是,如果你能夠將注意力集中在細節上,總會有更多的事情需要發現。例如,許多人認爲高股本回報率是有利的商業經濟的標誌,而另一些人則喜歡 “關注資金”,尋找內部人士正在買入的股票。雖然可能需要你進行一些研究,但你可能會發現這份免費收集的擁有高股本回報率的公司,或者這份內部人士正在購買的股票清單很有用。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對這篇文章有反饋嗎?對內容感到擔憂?直接聯繫我們。 或者,給編輯團隊 (at) simplywallst.com 發送電子郵件。
Simply Wall St的這篇文章本質上是籠統的。我們僅使用公正的方法根據歷史數據和分析師的預測提供評論,我們的文章無意作爲財務建議。它不構成買入或賣出任何股票的建議,也沒有考慮到您的目標或財務狀況。我們的目標是爲您提供由基本數據驅動的長期重點分析。請注意,我們的分析可能不考慮最新的價格敏感型公司公告或定性材料。簡而言之,華爾街沒有持有任何上述股票的頭寸。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論